New study asks women who inject drugs: would you take a shot to prevent HIV?
NCT ID NCT05799339
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 23 times
Summary
This study looked at how women who inject drugs feel about a long-acting injectable HIV prevention medication called CAB-LA. Researchers wanted to understand what helps or hinders their decision to use it, and how it compares to daily pills. The goal is to design better programs to support HIV prevention in this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Prevention Point Philadelphia
Philadelphia, Pennsylvania, 19143, United States
Conditions
Explore the condition pages connected to this study.